{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T06:05:32Z","timestamp":1778220332331,"version":"3.51.4"},"reference-count":23,"publisher":"American Psychiatric Association Publishing","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["AJP"],"published-print":{"date-parts":[[2002,11,1]]},"DOI":"10.1176\/appi.ajp.159.11.1876","type":"journal-article","created":{"date-parts":[[2002,10,31]],"date-time":"2002-10-31T23:05:49Z","timestamp":1036105549000},"page":"1876-1881","source":"Crossref","is-referenced-by-count":48,"title":["Effects of Metergoline on Symptoms in Women With Premenstrual Dysphoric Disorder"],"prefix":"10.1176","volume":"159","author":[{"given":"Catherine A.","family":"Roca","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter J.","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark J.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Merry A.","family":"Danaceau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dennis L.","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David R.","family":"Rubinow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"230","reference":[{"key":"R15911CHDHHBEJ","doi-asserted-by":"crossref","unstructured":"Wikander K, Sundblad C, Andersch B, Dagnell I, Zylberstein D, Bengtsson F, Eriksson E: Citalopram in premenstrual dysphoria: is intermittent treatment during luteal phases more effective than continuous medication throughout the menstrual cycle? J Clin Psychopharmacol 1998; 18:390-398","DOI":"10.1097\/00004714-199810000-00007"},{"key":"R15911CHDCGFGB","doi-asserted-by":"crossref","unstructured":"Lesch KP, Aulakh CS, Wolozin BL, Tolliver TJ, Hill JL, Murphy DL: Regional brain expression of serotonin transporter messenger-RNA and its regulation by reuptake inhibiting antidepressants. Mol Brain Res 1993; 17:31-35","DOI":"10.1016\/0169-328X(93)90069-2"},{"key":"R15911CHDHGJID","doi-asserted-by":"crossref","unstructured":"Ni YG, Miledi R: Blockage of 5HT2C serotonin receptors by fluoxetine (Prozac). Proc Natl Acad Sci USA 1997; 94:2036-2040","DOI":"10.1073\/pnas.94.5.2036"},{"key":"R15911CHDJBCHJ","doi-asserted-by":"crossref","unstructured":"Uzunova V, Sheline Y, Davis JM, Rasmusson A, Uzunov DP, Costa E, Guidotti A: Increase in the cerebrospinal fluid content of neurosteroids in patients with unipolar major depression who are receiving fluoxetine or fluvoxamine. Proc Natl Acad Sci USA 1998; 95:3239-3244","DOI":"10.1073\/pnas.95.6.3239"},{"key":"R15911CHDDDCBC","unstructured":"Kennett GA: 5-HT1C receptors and their therapeutic relevance. Curr Opin Invest Drugs 1993; 2:317-362"},{"key":"R15911CHDIGDDB","doi-asserted-by":"crossref","unstructured":"Fuxe K, Agnati L, Everitt B: Effects of metergoline on central monoamine neurons: evidence for a selective blockade of central 5-HT receptors. Neurosci Lett 1975; 1:283-290","DOI":"10.1016\/0304-3940(75)90044-0"},{"key":"R15911CHDGFEJC","doi-asserted-by":"crossref","unstructured":"Greenberg BD, Benjamin J, Martin JD, Keuler D, Huang SJ, Altemus M, Murphy DL: Delayed obsessive-compulsive disorder symptom exacerbation after a single dose of a serotonin antagonist in fluoxetine-treated but not untreated patients. Psychopharmacology (Berl) 1998; 140:434-444","DOI":"10.1007\/s002130050787"},{"key":"R15911CHDHIGGC","doi-asserted-by":"crossref","unstructured":"Su T-P, Schmidt PJ, Danaceau M, Murphy DL, Rubinow DR: Effect of menstrual cycle phase on neuroendocrine and behavioral responses to the serotonin agonist m-chlorophenylpiperazine in women with premenstrual syndrome and controls. J Clin Endocrinol Metab 1997; 82:1220-1228","DOI":"10.1210\/jc.82.4.1220"},{"key":"R15911CHDGEJBB","doi-asserted-by":"crossref","unstructured":"Zohar J, Mueller EA, Insel TR, Zohar-Kadouch RC, Murphy DL: Serotonergic responsivity in obsessive-compulsive disorder: comparison of patients and healthy controls. Arch Gen Psychiatry 1987; 44:946-951","DOI":"10.1001\/archpsyc.1987.01800230026006"},{"key":"R15911CHDJAHBI","doi-asserted-by":"crossref","unstructured":"Barr LC, Goodman WK, McDougle CJ, Delgado PL, Heninger GR, Charney DS, Price LH: Tryptophan depletion in patients with obsessive-compulsive disorder who respond to serotonin reuptake inhibitors. Arch Gen Psychiatry 1994; 51:309-317","DOI":"10.1001\/archpsyc.1994.03950040053007"},{"key":"R15911CHDDGIDJ","doi-asserted-by":"crossref","unstructured":"Menkes DB, Coates DC, Fawcett JP: Acute tryptophan depletion aggravates premenstrual syndrome. J Affect Disord 1994; 32:37-44","DOI":"10.1016\/0165-0327(94)90059-0"},{"key":"R15911CHDHBHII","doi-asserted-by":"crossref","unstructured":"Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J: An inventory for measuring depression. Arch Gen Psychiatry 1961; 4:561-571","DOI":"10.1001\/archpsyc.1961.01710120031004"},{"key":"R15911CHDHHABD","doi-asserted-by":"crossref","unstructured":"Steiner M, Haskett RF, Carroll BJ: Premenstrual tension syndrome: the development of research diagnostic criteria and new rating scales. Acta Psychiatr Scand 1980; 62:177-190","DOI":"10.1111\/j.1600-0447.1980.tb00605.x"},{"key":"R15911CHDEIEAG","doi-asserted-by":"crossref","unstructured":"Hamilton M: The assessment of anxiety states by rating. Br J Med Psychol 1959; 32:50-55","DOI":"10.1111\/j.2044-8341.1959.tb00467.x"},{"key":"R15911CHDHCJGD","doi-asserted-by":"crossref","unstructured":"Hamilton M: A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23:56-62","DOI":"10.1136\/jnnp.23.1.56"},{"key":"R15911CHDHAIIE","doi-asserted-by":"crossref","unstructured":"Van Kammen DP, Murphy DL: Attenuation of the euphoriant and activating effects of d- and l-amphetamine by lithium carbonate treatment. Psychopharmacologia 1975; 44:215-224","DOI":"10.1007\/BF00428897"},{"key":"R15911CHDDBDCH","doi-asserted-by":"crossref","unstructured":"Schnurr PP: Measuring amount of symptom change in the diagnosis of premenstrual syndrome. Psychol Assess 1989; 1:277-283","DOI":"10.1037\/\/1040-3590.1.4.277"},{"key":"R15911CHDFABHJ","doi-asserted-by":"crossref","unstructured":"Krulich L, McCann SM, Mayfield MA: On the mode of the prolactin release-inhibiting action of the serotonin receptor blockers metergoline, methysergide, and cyproheptadine. Endocrinology 1981; 108:1115-1124","DOI":"10.1210\/endo-108-4-1115"},{"key":"R15911CHDFGABA","doi-asserted-by":"crossref","unstructured":"Aubert ML, Becker RL, Saxena BB, Raiti S: Report of the National Pituitary Agency: collaborative study of the radioimmunoassay of human prolactin. J Clin Endocrinol Metab 1974; 38:1115-1120","DOI":"10.1210\/jcem-38-6-1115"},{"key":"R15911CHDBJABE","doi-asserted-by":"crossref","unstructured":"Sundblad C, Hedberg MA, Eriksson E: Clomipramine administered during the luteal phase reduces the symptoms of premenstrual syndrome: a placebo-controlled trial. Neuropsychopharmacology 1993; 9:133-145","DOI":"10.1038\/npp.1993.52"},{"key":"R15911CHDHHBDC","doi-asserted-by":"crossref","unstructured":"Guidotti A, Costa E: Can the antidysphoric and anxiolytic profiles of selective serotonin reuptake inhibitors be related to their ability to increase 3 alpha, 5 alpha-tetrahydroprogesterone (allopregnanolone) availability? Biol Psychiatry 1998; 44:865-873","DOI":"10.1016\/S0006-3223(98)00070-5"},{"key":"R15911CHDEHCAD","unstructured":"Sanders-Bush E, Breeding M: Serotonin1C receptor reserve in choroid plexus masks receptor subsensitivity. J Pharmacol Exp Ther 1990; 252:984-988"},{"key":"R15911CHDJIICH","unstructured":"Dennis T, Blier P, de Montigny C: Delayed effects of spiperone on serotonin 1A receptors in the dorsal hippocampus of rats. J Psychiatr Neurosci 1993; 18:264-275"}],"container-title":["American Journal of Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/psychiatryonline.org\/doi\/10.1176\/appi.ajp.159.11.1876","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,25]],"date-time":"2024-07-25T00:17:01Z","timestamp":1721866621000},"score":1,"resource":{"primary":{"URL":"https:\/\/psychiatryonline.org\/doi\/10.1176\/appi.ajp.159.11.1876"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,11,1]]},"references-count":23,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2002,11,1]]}},"alternative-id":["10.1176\/appi.ajp.159.11.1876"],"URL":"https:\/\/doi.org\/10.1176\/appi.ajp.159.11.1876","relation":{},"ISSN":["0002-953X","1535-7228"],"issn-type":[{"value":"0002-953X","type":"print"},{"value":"1535-7228","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,11,1]]}}}